GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 39 filers reported holding GALERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,659 | -93.6% | 106,564 | +13.2% | 0.00% | – |
| Q2 2023 | $293,792 | +38.7% | 94,164 | +13.8% | 0.00% | – |
| Q1 2023 | $211,876 | +147.2% | 82,764 | +43.9% | 0.00% | – |
| Q4 2022 | $85,716 | +71.4% | 57,528 | +100.0% | 0.00% | – |
| Q3 2022 | $50,000 | +35.1% | 28,764 | 0.0% | 0.00% | – |
| Q2 2022 | $37,000 | -45.6% | 28,764 | 0.0% | 0.00% | – |
| Q1 2022 | $68,000 | -42.9% | 28,764 | +11.2% | 0.00% | – |
| Q4 2021 | $119,000 | -43.1% | 25,864 | 0.0% | 0.00% | – |
| Q3 2021 | $209,000 | +33.1% | 25,864 | +62.0% | 0.00% | – |
| Q2 2021 | $157,000 | -86.1% | 15,964 | -87.5% | 0.00% | – |
| Q1 2021 | $1,128,000 | -9.0% | 127,941 | +5.6% | 0.00% | – |
| Q4 2020 | $1,239,000 | +65.6% | 121,141 | +46.4% | 0.00% | – |
| Q3 2020 | $748,000 | +22.6% | 82,772 | -3.1% | 0.00% | – |
| Q2 2020 | $610,000 | +326.6% | 85,421 | +466.3% | 0.00% | – |
| Q1 2020 | $143,000 | – | 15,084 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 3,083,712 | $40,582,000 | 2.92% |
| Novo Holdings A/S | 3,409,021 | $44,863,000 | 2.89% |
| NEA Management Company, LLC | 4,362,986 | $57,417,000 | 2.72% |
| SPHERA FUNDS MANAGEMENT LTD. | 471,439 | $6,204,000 | 0.51% |
| RA Capital Management | 1,054,178 | $13,873,000 | 0.42% |
| Rock Springs Capital Management LP | 500,000 | $6,580,000 | 0.21% |
| Tekla Capital Management LLC | 416,666 | $5,483,000 | 0.21% |
| Blackstone Inc. | 1,678,984 | $22,095,000 | 0.14% |
| Perceptive Advisors | 325,000 | $4,277,000 | 0.08% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,300,000 | $17,108,000 | 0.04% |